We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Ultrasound Renal Denervation: Interdisciplinary Approach to Better Patient Outcomes
Naomi Fisher, MD
Florian Rader, MD
Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
Jay Reddy, MD, FASN
Carlos Narváez Mejía, MD
Practical Management of Variceal Bleeding and Hepatorenal Syndrome
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Andrew Keaveny, MD
Don Rockey, MD
Understanding the Recent Advances in IgAN
Jürgen Floege, MD
Jonathan Barratt, PhD
Case-Based Management of Hyperkalemia to Optimize RAASi Therapy in Patients with CKD
Mikhail Kosiborod, MD
Biff F. Palmer, MD
I Just Need to Sleep! Improving Itch in Patients With CKD-aP
Kieran McCafferty, MD
Prof. Dr. Jörg Latus
Almost Like Being There: Updates in IgA Nephropathy From Kidney Week
Howard Trachtman, MD, FASN
Hiddo L. Heerspink, PhD
Why We Should Be PRO Patients With CKD-Associated Pruritus
Lucio Manenti, MD, PhD
Jeanette Finderup, PhD, MHR, RN
Sebastian Koball, MD
Exploring Developments in IgAN and FSGS
Richard Lafayette, MD, FACP
Addressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit?
Stefan D. Anker, MD, PhD
John Cleland, MD
Piotr Ponikowski, MD, PhD, FESC, FHFA
Hyperkalemia in CKD and HFrEF…What Am I Missing?
George L. Bakris, MD, FAHA, FASN
David Bushinsky, MD
Lars Lund, MD
Clinical Implications of the Evidence from IV Iron Trials in Heart Failure
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Richard Johnson, MD
Abdul Abdellatif, MD, FASN
John K. Botson, MD, RPh
Brittany Weber, MD, PhD
Gout Beyond the Joints: What’s the Hidden Danger?
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education